<DOC>
	<DOCNO>NCT01349647</DOCNO>
	<brief_summary>Even small cell lung cancer respond well treatment chemotherapy , tendency grow back spread . The investigator interested test new therapy aim decrease risk . This study test vaccine , substance inject skin cause immune response . The hope body make antibody vaccine also react cancer . The vaccine specific small cell lung cancer . It combine several component ( small cell lung cancer target ) test individually patient small cell lung cancer cancer ( GD2 , GD3 , Globo H , Fucosyl GM1 N-propionylated polysialic acid ) . Two substance ( KLH OPT-821 ) add boost immune system . This study two group patient . The first group receive vaccine along one cycle chemotherapy . The second group receive vaccine without chemotherapy .</brief_summary>
	<brief_title>Immunization With Pentavalent Vaccine Composed KLH-conjugates GD2L , GD3L , Globo H , Fucosyl GM1 , N-Propionylated Polysialic Acid</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients must small cell lung cancer confirm Department Pathology Memorial SloanKettering Cancer Center . Patients may limit extensive stage disease time diagnosis . Patients must complete firstline therapy , without thoracic and/or cranial irradiation , achieve either complete response partial response therapy without subsequent evidence disease progression . At least 3 week must elapse time patient complete chemotherapy first vaccination . No 8 week elapse time patient complete chemotherapy first vaccination . If patient receive thoracic cranial irradiation complete chemotherapy , least 1 week must elapse radiation first vaccination . Patients must recover acute toxicity radiation prior start vaccine therapy . Karnofsky Performance Status &gt; = 70 % . Hematologic parameter : WBC &gt; = 3.0 x 10^3 cells/µl Total lymphocyte count &gt; = 0.5 x 10^3 cells/µl Platelet count &gt; 100,000/µl Biochemical parameter Creatinine clearance &gt; = 40 ml/min Total bilirubin &lt; = 1.5 x upper limit normal AST ALT &lt; = 2.5 x upper limit normal Patients must able give write informed consent . Patients must ≥ 18 year old . Patients progression disease firstline chemotherapy . Pregnant lactating woman . Patients history immunodeficiency autoimmune disease , undergone radiation spleen splenectomy . Patients history leptomeningeal disease . Patients active infection require systemic antibiotic , antiviral , antifungal treatment . Patients serious unstable medical illness . Patients take systemic corticosteroid . Patients peripheral sensory neuropathy &gt; grade 1 . Patients use nonsteroidal antiinflammatory medication within 2 week vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>FUCOSYL-GM1-KLH</keyword>
	<keyword>GLOBO H-KLH CONJUGATE</keyword>
	<keyword>OPT-821</keyword>
	<keyword>POLYSIALIC ACID - KLH</keyword>
	<keyword>Vaccine</keyword>
	<keyword>08-095</keyword>
</DOC>